Once-monthly maridebart cafraglutide for the treatment of obesity - A phase 2 trial
These molecules are associated with cancer development and progression and may serve as potential therapeutic targets
doi: 10.3389/fphar.2023.1222195 Received 14 May 2023 Accepted 26 June 2023 Published 18 July 2023 Volume 14 - 2023 Edited by Wirginia Kukula-Koch, Medical University of Lublin, Poland Reviewed by Armando Caceres, Galileo University, Guatemala Laiba Arshad, Forman Christian College, Pakistan Poonam Arora, Shree Guru Gobind Singh Tricentenary University, India Updates Copyright 2023 Yuandani, Jantan, Haque, Rohani, Nugraha, Salim, Septama, Juwita, Khairunnisa, Nasution, Utami and Ibrahim
Can I get Vitamin B12 injections without a confirmed deficiency
Also discussing the promising synergy of Kisspeptin, Oxytocin, and PT-141